Form 4: MACOM CEO Stephen Daly Sells Over 24,000 Shares Under Pre-Arranged Trading Plan

Sentiment:

Insider Transaction Report


Stephen G. Daly, President and CEO of MACOM Technology Solutions Holdings, Inc., sold 24,039 shares of common stock in early June 2025 under a Rule 10b5-1 trading plan.

Summary

  • Stephen G. Daly, the President and CEO, and a Director of MACOM Technology Solutions Holdings, Inc. (MTSI), reported multiple sales of the company's common stock.
  • A total of 24,039 shares were disposed of across five separate transactions on June 2, 2025, and June 4, 2025.
  • The sales were executed at weighted average prices ranging from $122.05 to $128.26 per share.
  • These transactions were conducted pursuant to a Rule 10b5-1 sales plan adopted by Mr. Daly on February 28, 2025, which is designed to comply with insider trading regulations.
  • Following these reported transactions, Mr. Daly beneficially owns 26,953 shares of MACOM common stock directly.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to significant insider sales by the CEO, even though they were conducted under a pre-arranged 10b5-1 plan. While the plan mitigates concerns about opportunistic trading, the reduction in direct ownership by a key executive can still be viewed with caution by investors.

Positives

  • The sales were conducted under a Rule 10b5-1 trading plan, which indicates pre-planning and is intended to avoid accusations of insider trading, enhancing corporate governance transparency.
  • The execution of sales at increasing prices (from $122.05 to $128.26) suggests a rising stock price during the transaction period.

Negatives

  • The sale of a significant number of shares (24,039) by the President and CEO reduces his direct ownership stake in the company, which could be perceived by some investors as a lack of confidence, although mitigated by the 10b5-1 plan.
  • The total shares sold represent a substantial portion of his previous holdings (approximately 47% of his holdings prior to these sales).

Risks

  • While conducted under a 10b5-1 plan, large insider sales can sometimes lead to negative market sentiment or speculation regarding the company's future prospects, potentially impacting share price.
  • A reduction in insider ownership might be viewed by some investors as a decrease in alignment between management and shareholder interests.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future financial performance or strategic outlook.

Management Comments

  • The shares were sold pursuant to a sales plan adopted by the Reporting Person on February 28, 2025, and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.

Industry Context

This filing is specific to an insider transaction and does not provide broader industry context or trends. It reflects an individual's portfolio management rather than a company-wide strategic move.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Policy AdherenceThe reported stock sales were conducted under a Rule 10b5-1 trading plan, adopted on February 28, 2025. This demonstrates adherence to corporate governance best practices regarding insider trading, aiming to prevent any perception of trading on material non-public information.02/28/2025Positive impact on corporate governance transparency and compliance, as it provides a legal framework for insiders to sell shares without being accused of insider trading.

Stakeholder Impact

  • Shareholders: May interpret the CEO's stock sales differently; some may view it as a routine diversification or liquidity event under a pre-planned schedule, while others might see it as a signal of reduced confidence, despite the 10b5-1 plan.
  • Employees: No direct impact mentioned, but general market perception of insider sales could indirectly affect morale or confidence.

Key Dates

DateDescription
02/28/2025Date the Rule 10b5-1 sales plan was adopted by Stephen G. Daly.
06/02/2025Date of multiple common stock sales by Stephen G. Daly (5,415 shares, 4,020 shares, 5,230 shares).
06/04/2025Date of multiple common stock sales by Stephen G. Daly (6,946 shares, 2,428 shares) and the filing date of the Form 4.

Keywords

MACOM Technology Solutions Holdings, MTSI, Stephen G. Daly, Form 4, Insider Trading, Stock Sale, 10b5-1 Plan, Beneficial Ownership, CEO, Director

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.